Name | APTEKA N 64, OAO |
---|
INN | 5211001161 |
---|
KPP | 521101001 |
---|
OGRN | 1075222001106 |
---|
OKPO | 25699283 |
---|
FFSM | 12853-E |
---|
Address | 606260, Nizhegorodskaya oblast', r-n Vorotynskiy, rp. Vorotynets, ul. Kosmonavtov, d. 1 |
---|
Phone | 2-12-34 Contact details |
---|
Fax | +7 (831) 642-17-26 |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 03.12.2007 |
---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 10 po Nizhegorodskoy oblasti |
---|
|
APTEKA N 64, OAO (Nizhny Novgorod Oblast; INN 5211001161) was registered on 3 Dec 2007. The company's authorized capital as of July 1, 2012 was 718000 rub. Type of ownership of APTEKA N 64, OAO - Open joint-stock companies. Form of ownership of APTEKA N 64, OAO - Municipal property. Principal activities of APTEKA N 64, OAO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of APTEKA N 64, OAO dropped in 2023 by 41.53% to 145.00 thousand RUB from 248.00 thousand RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 2.01% to 47.68 million RUB from 48.66 million RUB in 2022; cost of goods sold decreased by 2.85% to 34.93 million RUB from 35.95 million RUB; sales profit fell by 17.64% to 920.00 thousand RUB from 1.12 million RUB. 2022
Net profit (RAS) of APTEKA N 64, OAO dropped in 2022 by 39.66% to 248.00 thousand RUB from 411.00 thousand RUB over the same period in 2021, the company informed. Revenue increased in the accounting period by 9.74% to 48.66 million RUB from 44.34 million RUB over 2021; cost of goods sold grew by 11.66% to 35.95 million RUB from 32.20 million RUB; sales profit fell by 28.12% to 1.12 million RUB from 1.55 million RUB. 2021
Net profit (RAS) of APTEKA N 64, OAO grew over 2021 1.52 times to 411.00 thousand RUB from 271.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 4.76% to 44.34 million RUB from 42.33 million RUB over 2020; cost of goods sold remained at the same level amounting to 32.20 million RUB compared to 32.21 million RUB; sales profit went up 3.90 times to 1.55 million RUB from 398.00 thousand RUB. 2020
Net profit (RAS) of APTEKA N 64, OAO grew over 2020 by 15.81% to 271.00 thousand RUB from 234.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period by 13.96% to 42.33 million RUB from 37.14 million RUB over 2019; cost of goods sold grew by 15.18% to 32.21 million RUB from 27.96 million RUB; sales profit went up by 1.53% to 398.00 thousand RUB from 392.00 thousand RUB. 2019
Net profit (RAS) of APTEKA N 64, OAO grew over 2019 by 38.46% to 234.00 thousand RUB from 169.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 3.41% to 37.14 million RUB from 35.92 million RUB over 2018; cost of goods sold grew by 3.68% to 27.96 million RUB from 26.97 million RUB; sales profit fell by 3.45% to 392.00 thousand RUB from 406.00 thousand RUB. 2018
Net profit (RAS) of APTEKA N 64, OAO grew over 2018 by 4.97% to 169.00 thousand RUB from 161.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 1.09% to 35.92 million RUB from 35.53 million RUB over 2017; cost of goods sold remained at the same level amounting to 26.97 million RUB compared to 26.97 million RUB; sales profit fell by 8.97% to 406.00 thousand RUB from 446.00 thousand RUB. 2017
Net profit (RAS) of APTEKA N 64, OAO grew over 2017 by 46.36% to 161.00 thousand RUB from 110.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period by 4.79% to 35.53 million RUB from 33.91 million RUB over 2016; cost of goods sold grew by 3.40% to 26.97 million RUB from 26.08 million RUB; sales profit went up by 13.20% to 446.00 thousand RUB from 394.00 thousand RUB. 2016
Net profit (RAS) of APTEKA N 64, OAO grew over 2016 1.75 times to 110.00 thousand RUB from 63.00 thousand RUB over 2015, the company informed. Revenue decreased in the accounting period by 13.16% to 33.91 million RUB from 39.05 million RUB in 2015; cost of goods sold decreased by 13.71% to 26.08 million RUB from 30.23 million RUB; sales profit went up by 2.07% to 394.00 thousand RUB from 386.00 thousand RUB. 2014
Net profit (RAS) of Apteka N 64, OAO grew over 2014 by 0.58% to 346.00 thousand RUB from 344.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 11.91% to 45.03 million RUB from 40.24 million RUB over 2013; cost of goods sold grew by 11.31% to 34.94 million RUB from 31.39 million RUB; sales profit fell by 7.49% to 432.00 thousand RUB from 467.00 thousand RUB. 2013
Net profit (RAS) of Apteka N 64, OAO grew over 2013 4.14 times to 344.00 thousand RUB from 83.00 thousand RUB over 2012, the company informed. Revenue increased in the accounting period by 7.83% to 40.24 million RUB from 37.32 million RUB over 2012; cost of goods sold grew by 8.84% to 31.39 million RUB from 28.84 million RUB; sales profit went up 3.01 times to 467.00 thousand RUB from 155.00 thousand RUB. 2012
Net profit (RAS) of Apteka N 64, OAO grew over 2012 by 22.06% to 83.00 thousand RUB from 68.00 thousand RUB over 2011, the company informed. Cost of goods sold grew by 14.63% to 28.84 million RUB from 25.16 million RUB; sales profit fell by 25.48% to 155.00 thousand RUB from 208.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|